File Download
  Patent History
  • Application
    CN 2010849820 2010-10-27
  • Granted
    CN 102741262 2012-10-17
  Patent Family
Supplementary

granted patent: Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment

TitlePharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment
Granted PatentCN 102741262
Granted Date2012-10-17
Priority Date2010-10-27 PCT/CN2010001705
2009-10-28 US 12/255667P
2010-02-05 US 12/301752P
Inventors
CHE, CHIMINGSUN, WAIYIN RAYMONDCHOW, LOKFUNGYAN, JING
Issue Date2012
Citation
China Patent CN 102741262. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2012 How to Cite?
AbstractThe present invention discloses a pharmaceutical composition for treating cancers, comprising a cyclometalated N-heterocyclic carbene complex. Said cyclometalated N-heterocyclic carbene complex contains a gold (III) or platinum (II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.
Persistent Identifierhttp://hdl.handle.net/10722/206623

 

DC FieldValueLanguage
dc.date.accessioned2014-11-21T08:07:23Z-
dc.date.available2014-11-21T08:07:23Z-
dc.date.issued2012en_US
dc.identifier.citationChina Patent CN 102741262. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2012en_US
dc.identifier.urihttp://hdl.handle.net/10722/206623-
dc.description.abstractThe present invention discloses a pharmaceutical composition for treating cancers, comprising a cyclometalated N-heterocyclic carbene complex. Said cyclometalated N-heterocyclic carbene complex contains a gold (III) or platinum (II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.en_US
dc.titlePharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatmenten_US
dc.typePatenten_US
dc.identifier.authorityCHE, CHIMING=rp00670en_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorCHE, CHIMINGen_US
dc.contributor.inventorSUN, WAIYIN RAYMONDen_US
dc.contributor.inventorCHOW, LOKFUNGen_US
dc.contributor.inventorYAN, JINGen_US
patents.identifier.applicationCN 2010849820en_US
patents.identifier.applicationZL201080049820.X-
patents.identifier.grantedCN 102741262en_US
patents.description.assigneeUNIV HONG KONGen_US
patents.description.countryChina, PRCen_US
patents.date.granted2012-10-17en_US
patents.identifier.hkutechidChm-2009-00331-2en_US
patents.date.application2010-10-27en_US
patents.date.priority2010-10-27 PCT/CN2010001705en_US
patents.date.priority2009-10-28 US 12/255667Pen_US
patents.date.priority2010-02-05 US 12/301752Pen_US
patents.description.cccnen_US
patents.relation.familyEP 2493896 (A1) 2012-09-05en_US
patents.relation.familyUS 2011098264 (A1) 2011-04-28en_US
patents.relation.familyU S8530659 (B2) 2013-09-10en_US
patents.relation.familyUS 2013324511 (A1) 2013-12-05en_US
patents.relation.familyWO 2011050574 (A1) 2011-05-05en_US
patents.description.kindAen_US
patents.typePatent_granteden_US

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats